Cargando…
Acute effect of antiseizure drugs on background oscillations in Scn1a (A1783V) Dravet syndrome mouse model
Dravet syndrome (Dravet) is a rare and severe form of developmental epileptic encephalopathy. Antiseizure medications (ASMs) for Dravet patients include valproic acid (VA) or clobazam (CLB), with or without stiripentol (STP), while sodium channel blockers like carbamazepine (CBZ) or lamotrigine (LTG...
Autores principales: | Quinn, Shir, Brusel, Marina, Ovadia, Mor, Rubinstein, Moran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067575/ https://www.ncbi.nlm.nih.gov/pubmed/37021051 http://dx.doi.org/10.3389/fphar.2023.1118216 |
Ejemplares similares
-
Dravet Variant SCN1A(A1783V) Impairs Interneuron Firing Predominantly by Altered Channel Activation
por: Layer, Nikolas, et al.
Publicado: (2021) -
Heat-induced seizures, premature mortality, and hyperactivity in a novel Scn1a nonsense model for Dravet syndrome
por: Mavashov, Anat, et al.
Publicado: (2023) -
Functional Investigation of a Neuronal Microcircuit in the CA1 Area of the Hippocampus Reveals Synaptic Dysfunction in Dravet Syndrome Mice
por: Almog, Yael, et al.
Publicado: (2022) -
Efficacy and safety of adjunctive antiseizure medications for dravet syndrome: A systematic review and network meta-analysis
por: Wu, Jianhua, et al.
Publicado: (2022) -
The Heat Sensing Trpv1 Receptor Is Not a Viable Anticonvulsant Drug Target in the Scn1a
(+/−) Mouse Model of Dravet Syndrome
por: Satpute Janve, Vaishali, et al.
Publicado: (2021)